What does VS Digital Health pricing mean for a clinic P&L?

You can plan patient price points, refill cadence, and which SKUs drive volume. What you cannot plan up front with VSDH is the COGS number itself, because wholesale per-vial rates are partner-gated. You also cannot fully model platform overhead until you know the annual license, revenue-share percentage, and whether VSDHOne state licenses apply. That gap matters most for high-volume GLP-1 programs, where a small per-vial difference plus a revenue-share layer multiplied across hundreds of monthly refills swings the bottom line.

Before margin depends on it, ask for written per-vial wholesale on your top three SKUs, the revenue-share basis and percentage on pharmacy orders, and whether shipping and cold-chain handling are included in wholesale or billed separately. Build your margin model on the all-in delivered cost per vial plus platform economics amortized across expected order volume — not a headline wholesale rate from a sales deck.

Fizy Health inverts the planning problem for clinics that already prescribe. It shows resolved per-vial 503A cost on each catalog and cart line before checkout, with a separately disclosed facilitation fee at payment and no revenue share on pharmacy orders. For a P&L, COGS is a number you can read before you commit, so you set patient pricing and project gross margin from day one.

Building the whole refill day in one cart reinforces the model: each line shows its cost, so you see total COGS for a batch and the margin it implies before you submit a single payment. Owners who manage to a target gross margin get a faster loop — see cost, set price, confirm spread — without waiting on a white-label agreement to fill in the most important line on the page.